1. Home
  2. SBSI vs CTMX Comparison

SBSI vs CTMX Comparison

Compare SBSI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southside Bancshares Inc.

SBSI

Southside Bancshares Inc.

HOLD

Current Price

$32.79

Market Cap

974.1M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSI
CTMX
Founded
1960
2008
Country
United States
United States
Employees
781
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.1M
977.1M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
SBSI
CTMX
Price
$32.79
$3.76
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$35.33
$12.10
AVG Volume (30 Days)
64.2K
2.8M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
4.42%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$28.87
N/A
Revenue Next Year
$5.82
$7.61
P/E Ratio
$42.18
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$26.32
$1.72
52 Week High
$34.53
$8.21

Technical Indicators

Market Signals
Indicator
SBSI
CTMX
Relative Strength Index (RSI) 51.43 39.49
Support Level $31.82 $3.39
Resistance Level $34.06 $3.91
Average True Range (ATR) 0.70 0.20
MACD -0.06 0.00
Stochastic Oscillator 52.80 39.76

Price Performance

Historical Comparison
SBSI
CTMX

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: